ABCL

NASD AbCellera Biologics, Inc.
Oct 1, 2026 · 2:27 PM ET DELAYED Market Open

$13.79 ↓ -0.80 (-5.48%) Trading Down from the previous close of $14.59, $0.86 below the day’s high of $14.65

YTD change
+303.22%
vs 20-day SMA
+12.98%
vs 200-day SMA
+134.56%

Price ranges

Previous day
$14.56 $15.02
open $14.78 close $14.59
-$0.19 (-1.29%)
Today
$13.79 $14.65
open $14.60 now $13.79
-$0.81 (-5.55%)
Past week
$11.78 $15.02
from $12.31 now $13.79
+$1.48 (+12.02%)
Past month
$10.32 $15.02
from $11.28 now $13.79
+$2.51 (+22.25%)
This year
$2.75 $15.02
from $3.42 now $13.79
+$10.37 (+303.22%)

Price & Performance

+11.08 (+315.67%) / 6M

$2.38$6.83$11.29$15.74Apr 1Jul 1Sep 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 80.8% away from all-time highs of $71.91
  • ABCL is up 303% since the beginning of the year
  • ABCL is up 131% over the past 12 months
  • ABCL is up 22% over the past 1 month
  • 13% of all ABCL investors are betting against ABCL

ABCL reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +144.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.18
Earnings momentum -3.3% Quarterly EPS growth
Quarterly change -3.3%

Valuation

P/E ratio N/A
Enterprise value $4.0B
Beta 2.47

Balance sheet & scale

IncomeN/A
Revenue$65.7M
Cash$565.1M
Debt$135.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $4.5B

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $421.51 -0.50%
MRNA Moderna, Inc. $192.57 -5.35%
RVMD Revolution Medicines, Inc. $205.26 +0.38%
ROIV Roivant Sciences Ltd. $36.57 +0.19%
BNTX BioNTech SE Sponsored ADR $98.30 -0.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.